Clinical Trials Browser

Phase 2 × tosedostat × Other hematologic neoplasm × Clear all

NCT00780598 2012-06-28

OPAL

Phase 2 Completed

Other hematologic neoplasm

Hematologic Diseases, Neoplasms, Recurrence, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT01180426 2012-02-15

Extension Study With Tosedostat in Relapsed/Refractory Acute Myeloid Leukemia

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute